Angel Biotechnology, based in Edinburgh, Scotland, (website) is a world class, contract Biopharmaceutical Company with extensive experience in regenerative stem cell and autologous cell therapy production to cGMP standards. Angel Biotechnology Holdings plc holds a Manufacturing Licence for Investigational Medicinal Products and Angel’s manufacturing facility at Pentlands Science Park in Edinburgh was licensed by the MHRA in July 2005 allowing Angel to manufacture cellular therapies and stem cells for use in clinical trials. These facilities are also licensed by the Human Tissue Authority which regulates storage, use and disposal of human tissue in the UK. The Cell Culture Team at Angel has considerable experience with primary human stem cells and autologous cell therapies in addition to process development, scale-up methods and production of Master Cell Banks and Working Cell Banks to cGMP standards. Angel Biotechnology Holdings plc is currently the manufacturing partner of a UK Department of Trade and Industry-funded consortium for development of stem cell therapy and has successfully manufactured a cGMP cell bank of neuronal stem cells for the treatment of human neurological diseases.

Angel Biotechnology's contribution to the Osteocord project is the assessment of CB-MSC production protocols: establishment of universal SOPs for culture maintenance as well as standardisation/optimisation of expansion and cryopreservation protocols for GMP production.

Angel Biotechnology Holdings plc, 50 Broadway, London, SW1H 0BL, UK

Angela Scott e-mail

Click on the links to access the other Partners:

1. University of York, UK
2. University Hospital of Odense, Denmark
3. University of Southern Denmark
4. Fraunhofer Institute for Biomedical Engineering
5. University of Nottingham, UK
6. Institute of Transfusion Medicine and Immunology, Mannheim, Germany
7. Angel Biotechnology, Edinburgh, Scotland
8. EC Bio, Oeiras, Portugal
9. Regentec, Nottingham, UK